I. Epidemiology --;1. Cardiac disease in chronic uremia: An overview --;2. Lessons from Framingham: Cardiac disease in the general population --;3. The natural history of myocardial disease in dialysis patients --;4. Ischemic heart disease in chronic renal failure: Demography, epidemiology, and pathogenesis --;5. Cardiac arrhythmias in end-stage renal disease: Prevalence, risk factors, and management --;II. Pathogenesis --;6. Cardiac pathology in chronic renal failure --;7. Etiology of left ventricular dysfunction in end-stage renal failure --;8. Left ventricular dysfunction in end-stage renal disease: Echocardiographic insights --;9. Parathyroid hormone and the myocardiopathy of chronic renal failure --;10. Anemia and left ventricular function in end-stage renal disease --;11. The effect of dialysis on left ventricular contractility --;12. Atherogenesis in chronic renal failure --;13. The heart in diabetic nephropathy --;III. Management --;14. The management of congestive heart failure in uremic patients --;15. The management of coronary artery disease in patients with end-stage renal disease --;16. Therapy of hypertension in end-stage renal disease --;17. The use of cardiovascular drugs in chronic renal failure --;18. Dialysis therapy in patients with cardiac disease.
The first section comprises five chapters that provide an overview of the burden of illness associated with cardiac disease in end-stage renal disease and a review of clinical epidemi- ological aspects of various cardiac diseases that occur in renal patients.